ENTX

MKT CAP:$52M

Entera Bio Ltd.

Market Cap

$52M

Healthcare·Biotechnology·🇮🇱 Israel·NASDAQ

Healthcare·Biotechnology·🇮🇱·NASDAQ

Stock Price

$1.17-$0.60 (-33.90%)

Apr 23, 2026

Company Details

Entera Bio Ltd., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of orally delivered large molecule therapeutics for unmet medical needs. The company's lead product candidates include the EB612, ...

CEO

Miranda J. Toledano

IPO Date

Jun 28, 2018

Website

www.enterabio.com

Key Metrics TTM

Revenue

$42.0K

-76.8% YoY

Net Income

-$11M

EPS (Diluted)

-$0.25

Free Cash Flow

-$20M

Revenue / Share

$0.00

Gross Margin

-35.7%

Operating Margin

-27450.0%

Net Margin

-27235.7%

FCF Margin

-48465.2%

P/S

1248.8x

P/E

—

Earnings Reports

Q1 2026

May 8, 2026

PENDING

FY 2025

Mar 27, 2026

$42.0K-76.8%EPS -$0.25

Q4 2025

Mar 27, 2026

$0-100.0%EPS -$0.07

Q3 2025

Nov 14, 2025

$0-100.0%EPS -$0.07

Q2 2025

Aug 8, 2025

$0-100.0%EPS -$0.06

Revenue & Profitability

Quarter	Revenue	Gross Profit	Operating Income
Q1 22	$68.0K	$14.0K	-$4M
Q2 22	$44.0K	$11.0K	-$3M
Q3 22	$8.0K	$2.0K	-$3M
Q4 22	$14.0K	-$10.0K	-$3M
Q1 23	$0	-$14.0K	-$2M
Q2 23	$0	-$15.0K	-$2M
Q3 23	$0	-$14.0K	-$2M
Q4 23	$0	-$13.0K	-$2M
Q1 24	$0	-$13.0K	-$2M
Q2 24	$57.0K	$9.0K	-$2M
Q3 24	$42.0K	$0	-$3M
Q4 24	$82.0K	$0	-$2M
Q1 25	$42.0K	$0	-$3M
Q2 25	$0	$0	-$3M
Q3 25	$0	-$8.0K	-$3M
Q4 25	$0	-$7.0K	-$3M

Valuation

Quarter	P/S	P/E
Q1 22	139.7x	—
Q2 22	104.3x	—
Q3 22	102.1x	—
Q4 22	204.2x	—
Q1 23	436.6x	—
Q2 23	1148.6x	—
Q3 23	1464.0x	—
Q4 23	—	—
Q1 24	—	—
Q2 24	1162.4x	—
Q3 24	722.5x	—
Q4 24	453.4x	—
Q1 25	287.0x	—
Q2 25	496.5x	—
Q3 25	736.5x	—
Q4 25	2018.1x	—

Operating Cash Flow

Quarter	Operating CF	Free CF
Q1 22	-$5M	-$5M
Q2 22	-$3M	-$3M
Q3 22	-$3M	-$3M
Q4 22	-$2M	-$2M
Q1 23	-$2M	-$2M
Q2 23	-$2M	-$2M
Q3 23	-$2M	-$2M
Q4 23	-$3M	-$3M
Q1 24	-$2M	-$2M
Q2 24	-$1M	-$1M
Q3 24	-$2M	-$2M
Q4 24	-$1M	-$1M
Q1 25	-$1M	-$1M
Q2 25	-$2M	-$2M
Q3 25	-$3M	-$3M
Q4 25	-$14M	-$14M

Capital Expenditures

Quarter	CapEx
Q1 22	$23.0K
Q2 22	$18.1K
Q3 22	$2.0K
Q4 22	$2.6K
Q1 23	$11.0K
Q2 23	$808
Q3 23	$185
Q4 23	$4.8K
Q1 24	$0
Q2 24	$0
Q3 24	$0
Q4 24	$3.0K
Q1 25	$8.0K
Q2 25	$29.2K
Q3 25	$46.5K
Q4 25	$27.0K

CapEx

OpEx vs Revenue Growth (YoY)

Quarter	Revenue Growth	OpEx Growth
Q1 22	-69.2%	+55.1%
Q2 22	-72.0%	+31.9%
Q3 22	-94.3%	+193.3%
Q4 22	-91.5%	-27.8%
Q1 23	-100.0%	-43.0%
Q2 23	-100.0%	-28.8%
Q3 23	-100.0%	-16.5%
Q4 23	-100.0%	-36.4%
Q1 24	—	-7.3%
Q2 24	—	-5.2%
Q3 24	—	+27.7%
Q4 24	—	+22.6%
Q1 25	—	+26.3%
Q2 25	-100.0%	+20.1%
Q3 25	-100.0%	+6.3%
Q4 25	-100.0%	+25.8%

Stock-Based Compensation

Quarter	SBC ($)	% of Revenue
Q1 22	$964.0K	1417.6%
Q2 22	$0	0.0%
Q3 22	$110.0K	1375.0%
Q4 22	$0	0.0%
Q1 23	$516.0K	—
Q2 23	$0	—
Q3 23	$383.0K	—
Q4 23	$0	—
Q1 24	$464.0K	—
Q2 24	$598.0K	1049.1%
Q3 24	$928.0K	2209.5%
Q4 24	$566.0K	690.2%
Q1 25	$604.0K	1438.1%
Q2 25	$0	—
Q3 25	$0	—
Q4 25	$710.0K	—

OpEx Breakdown

Quarter	R&D	G&A	SG&A
Q1 22	$2M	$2M	—
Q2 22	$1M	$2M	—
Q3 22	$1M	$1M	—
Q4 22	$1M	—	$2M
Q1 23	$917.0K	—	$1M
Q2 23	$1M	—	$1M
Q3 23	$1M	—	$1M
Q4 23	$987.0K	—	$973.0K
Q1 24	$722.0K	$1M	—
Q2 24	$1M	$1M	—
Q3 24	$1M	$2M	—
Q4 24	$1M	$1M	—
Q1 25	$1M	$1M	—
Q2 25	$2M	$1M	—
Q3 25	$2M	$2M	—
Q4 25	$2M	$1M	—

War Chest

Quarter	Cash	Short-term Investments	Total
Q1 22	$20M	$0	$20M
Q2 22	$17M	$0	$17M
Q3 22	$14M	$0	$14M
Q4 22	$12M	$0	$12M
Q1 23	$11M	$0	$11M
Q2 23	$9M	$0	$9M
Q3 23	$8M	$0	$8M
Q4 23	$11M	$0	$11M
Q1 24	$9M	$0	$9M
Q2 24	$9M	$0	$9M
Q3 24	$7M	$0	$7M
Q4 24	$9M	$0	$9M
Q1 25	$13M	$0	$13M
Q2 25	$11M	$0	$11M
Q3 25	$9M	$0	$9M
Q4 25	$7M	$0	$7M

Shares Outstanding

Quarter	Shares (Diluted)	QoQ Change	YoY Change
Q1 22	29M	+0.4%	+57.1%
Q2 22	29M	+0.0%	+31.6%
Q3 22	29M	+0.0%	+0.5%
Q4 22	29M	0.0%	+0.5%
Q1 23	29M	0.0%	+0.0%
Q2 23	29M	+0.0%	+0.0%
Q3 23	29M	+0.0%	+0.0%
Q4 23	30M	+3.1%	+3.1%
Q1 24	37M	+23.7%	+27.5%
Q2 24	37M	+1.0%	+28.7%
Q3 24	38M	+1.5%	+30.6%
Q4 24	38M	+0.0%	+26.7%
Q1 25	43M	+15.2%	+18.1%
Q2 25	47M	+8.0%	+26.3%
Q3 25	47M	+0.5%	+25.1%
Q4 25	46M	-1.9%	+22.7%

Shares Outstanding

Revenue Per Employee

Period	Revenue/Employee	Employees
Q1 22	$3.2K	21
Q2 22	$2.1K	21
Q3 22	$381	21
Q4 22	$700	20
Q1 23	$0	20
Q2 23	$0	20
Q3 23	$0	20
Q4 23	$0	19
Q1 24	$0	19
Q2 24	$3.0K	19
Q3 24	$2.2K	19
Q4 24	$4.1K	20
Q1 25	$2.1K	20
Q2 25	$0	20
Q3 25	$0	20
Q4 25	$0	177K

Revenue / Employee